YPSNZ Stock Overview
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Ypsomed Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF331.25 |
| 52 Week High | CHF389.50 |
| 52 Week Low | CHF225.00 |
| Beta | 1.0 |
| 1 Month Change | -12.83% |
| 3 Month Change | -3.71% |
| 1 Year Change | 41.26% |
| 3 Year Change | 124.73% |
| 5 Year Change | 146.47% |
| Change since IPO | 509.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| YPSNZ | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 1.1% | 1.2% | 2.5% |
| 1Y | 41.3% | -10.0% | 5.8% |
Return vs Industry: YPSNZ exceeded the UK Medical Equipment industry which returned -10% over the past year.
Return vs Market: YPSNZ exceeded the UK Market which returned 5.8% over the past year.
Price Volatility
| YPSNZ volatility | |
|---|---|
| YPSNZ Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: YPSNZ has not had significant price volatility in the past 3 months.
Volatility Over Time: YPSNZ's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,200 | Simon Michel | www.ypsomed.com |
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices.
Ypsomed Holding AG Fundamentals Summary
| YPSNZ fundamental statistics | |
|---|---|
| Market cap | CHF4.53b |
| Earnings (TTM) | CHF72.42m |
| Revenue (TTM) | CHF508.61m |
62.6x
P/E Ratio8.9x
P/S RatioIs YPSNZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YPSNZ income statement (TTM) | |
|---|---|
| Revenue | CHF508.61m |
| Cost of Revenue | CHF345.64m |
| Gross Profit | CHF162.96m |
| Other Expenses | CHF90.55m |
| Earnings | CHF72.42m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 22, 2024
| Earnings per share (EPS) | 5.31 |
| Gross Margin | 32.04% |
| Net Profit Margin | 14.24% |
| Debt/Equity Ratio | 35.4% |
How did YPSNZ perform over the long term?
See historical performance and comparison